Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Inhibitors of poly(ADP-ribose) polymerase activity as interventions against renal ischemia/reperfusion injury and acute renal failure

P. Chatterjee, M. McDonald, M. Threadgill, C. Thiemermann

Med Sci Monit 2003; 9(1): 10-0 :: ID: 15056

Abstract

Excessive activation of PARP contributes to the renal dysfunction and injury caused by reactive oxygen species (ROS), nitric oxide and peroxynitrite [1]. However, most inhibitors of PARP activity are either weak inhibitors (e.g. 3-aminobenzamide) or are soluble in dimethyl sulphoxide (e.g. 5-dihydroxyisoquinoline). We therefore investigated the effects of the water-soluble PARP inhibitor, 5-aminoisoquinolinone (5-AIQ), on the (i) renal dysfunction caused by 45 min ischaemia followed by 6 h reperfusion (I/R) in vivo and (ii) cytotoxicity caused by exposure of rat proximal tubular (PT) cells to oxidative stress (1 mM H2O2 for 4 h) in vitro.Renal I/R produced a significant increase in serum creatinine levels (indicating renal dysfunction) which was reduced significantly by 5-AIQ (Table 1). Incubation of rat PT cells with H2O2 increased LDH significantly (indicating renal cytotoxicity) (Table 2), however, incubation with H2O2 and 5-AIQ produced a significant reduction in LDH release (Table 2).Thus we propose that PARP inhibitors may be useful in conditions which involve renal ischaemia and reperfusion (e.g. renal transplantation).References: 1.Chatterjee PK, Thiemermann C: Poly(ADP-ribose) polymerase inhibitors and acute renal failure. In: Zhang J (ed.): Therapeutic Utilities of PARP Inhibitors. CRC Press; Boca Raton, 2002, pp. 149-168

Keywords: renal, Kidney, proximal tubular cells, poly(ADP-ribose) polymerase, poly(ADP-ribose) polymerase inhibitor, 5-aminoisoquinolinone, 5-dihydroxyisoquinolinoline

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750